Inmunomodulación y Microambiente Tumoral
ITAM
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (1)
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1